Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Share News (IBT)

Share Price Information for Int.biotech. (IBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 634.00
Bid: 630.00
Ask: 634.00
Change: -2.00 (-0.31%)
Spread: 4.00 (0.635%)
Open: 626.00
High: 634.00
Low: 626.00
Prev. Close: 636.00
IBT Live PriceLast checked at -
International Biotechnology is an Investment Trust

To achieve capital growth through investing in high growth, development stage biotechnology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS SUMMARY: Vulcan Industries and Wildcat Petroleum narrow loss

Tue, 01st Nov 2022 14:48

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Bowleven PLC - Africa-focused oil and gas exploration firm focussed on Cameroon - Pretax loss in the financial year that ended June 30 widens to USD2.5 million from USD2.0 million a year prior. Posts no revenue, unchanged. Reports a negative finance & other income of USD108,000, swinging from a gain of USD820,000 a year ago. Looking ahead, firm says it is currently discussing debt and equity issues and hybrid debt instruments to raise more funding during early 2023. Bowleven ends its financial year 2022 with USD1.3 million of cash and a financial investment of USD2.2 million.

----------

International Biotechnology Trust PLC - London-based investment trust managed by SV Health Managers LLP - Net asset value per share at August 31 falls 11% to 697.2 pence from 782.4p a year ago. NAV total return turns to negative 6.9% from positive 9.8% a year prior. Chair Jim Horsburgh announces his retirement at the conclusion of the annual general meeting on December 6 after nine years at the board. New chair will be Kate Cornish-Bowden, who has been on the board since 2020. "With the fundamentals for the biotechnology sector looking attractive, I am optimistic that the company can look to the future with confidence," says outgoing Chair Horsburgh.

----------

Vulcan Industries PLC - London-based engineering services firm - Pretax loss in the half-year that ended September 30 narrows to GBP547,000 from GBP609,000 a year prior. Revenue jumps to GBP1.2 million from GBP491,000. Cost of sales widen to GBP929,000 from GBP436,000. The company believes the planned acquisition of Peregrine X Ltd will help Vulcan become a profitable trading business in the next years. On October 14, Vulcan said it will buy the developer of an analytical tool and algorithms for a total consideration of GBP5.0 million.

----------

Wildcat Petroleum PLC - Uxbridge, England-based company targeting investment opportunities in the upstream sector of the petroleum industry, namely the exploration, appraisal, development and production of oil and gas - Pretax loss in the financial year that ended June 30 narrows to GBP305,744 from GBP459,646 a year prior. Notes that it raised money in its financial fourth quarter "to fund its ongoing and project start-up costs". Further, on Thursday last week firm said it is placing 18.0 million new shares at 1.25 pence each to raise GBP225,000, or net GBP211,970. The placing is for strengthening its balance sheet "in difficult market conditions," Wildcat Chair Mandhir Singh says.

----------

By Tom Budszus; tombudszus@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
22 Apr 2014 11:52

International Biotechnology Trust Net Asset Value Rises In Half-Year

LONDON (Alliance News) - International Biotechnology Trust PLC said Tuesday that it had seen its net asset value per share rise in the half-year to February 28, 2014, although it under-performed the NASDAQ Biotechnology Index. The trust posted a total return on net asset value per share of

Read more
11 Apr 2014 08:17

STOCKS NEWS EUROPE-Biotechs hit as UK small caps fall

The FTSE Small Cap Index falls 0.4 percent while the junior-listed FTSE AIM All Share Index retreats 0.8 percent, broadly tracking a 0.8 percent drop on the blue-chip FTSE 100 index. The FTSE 250 mid-cap index falls 1.2 percent. Oxford BioMedica declines by 2.9 percent, as brokerage N

Read more
11 Apr 2014 05:13

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
10 Apr 2014 15:09

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
10 Apr 2014 05:09

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
9 Apr 2014 15:25

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
9 Apr 2014 05:30

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
8 Apr 2014 15:14

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
8 Apr 2014 05:12

UK Earnings, Trading Statements Calendar - Week Ahead

Tuesday, April 8 
Netplay TV

Read more
7 Apr 2014 14:50

UK Earnings, Trading Statements Calendar - Week Ahead

Tuesday, April 8 
Netplay TV

Read more
7 Apr 2014 05:28

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
4 Apr 2014 15:00

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar 
Read more
28 Feb 2014 17:00

DIRECTOR DEALINGS: International Biotechnology Trust Non-Executive, Partners Buy Shares

LONDON (Alliance News) - International Biotechnology Trust PLC said Friday that non-executive director Jim Horsburgh bought 5,000 shares at 330.94 pence each. Horsburgh's total holding following the transaction is 0.02%. Kate Bingham, a partner of the company's investment manager SV L

Read more
28 Feb 2014 16:18

XP Power board members reduce holdings

XP Power's Chairman, Larry Tracey, on Thursday sold 75,000 shares in the power supply solutions manufacturer. Tracey, who has held his current role since April 2002, disposed of the shares at 1,755p a time, generating a total of £1.3m. Fellow board member James Peters, a Non-Executive Director, t

Read more
13 Feb 2014 14:54

International Biotechnology Trust Ups Valuation Of Affinium Interest After Sale

LONDON (Alliance News) - The International Biotechnology Trust PLC Thursday said it has upped the valuation of its interest in Affinium Pharmaceuticals, an unquoted portfolio company, after it was sold to Debiopharm Group. In a statement, the trust said it upped the valuation of its interes

Read more

Quickpicks are a member only feature

Login to your account